Related references
Note: Only part of the references are listed.Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
Norman Sachs et al.
CELL (2018)
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
Yi-Mi Wu et al.
CELL (2018)
Mutational signatures of DNA mismatch repair deficiency in C. elegans and human cancers
Bettina Meier et al.
GENOME RESEARCH (2018)
Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair
N. J. Haradhvala et al.
NATURE COMMUNICATIONS (2018)
Validating the concept of mutational signatures with isogenic cell models
Xueqing Zou et al.
NATURE COMMUNICATIONS (2018)
MutationalPatterns: comprehensive genome-wide analysis of mutational processes
Francis Blokzijl et al.
GENOME MEDICINE (2018)
EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma
Aparna Gorthi et al.
NATURE (2018)
Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions
J. Zamborszky et al.
ONCOGENE (2017)
The whole-genome landscape of medulloblastoma subtypes
Paul A. Northcott et al.
NATURE (2017)
Genomic hallmarks of localized, non-indolent prostate cancer
Michael Fraser et al.
NATURE (2017)
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
Paz Polak et al.
NATURE GENETICS (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
Helen Davies et al.
NATURE MEDICINE (2017)
Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer
Jarno Drost et al.
SCIENCE (2017)
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
Melinda L. Telli et al.
CLINICAL CANCER RESEARCH (2016)
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal et al.
NATURE (2016)
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
M. R. Mirza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing
Eric Talevich et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution
Rachel Rosenthal et al.
GENOME BIOLOGY (2016)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
Clock-like mutational processes in human somatic cells
Ludmil B. Alexandrov et al.
NATURE GENETICS (2015)
APOBEC-Induced Cancer Mutations Are Uniquely Enriched in Early-Replicating, Gene-Dense, and Active Chromatin Regions
Marat D. Kazanov et al.
CELL REPORTS (2015)
8-oxoguanine causes spontaneous de novo germline mutations in mice
Mizuki Ohno et al.
SCIENTIFIC REPORTS (2014)
An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules
Amrita Basu et al.
CELL (2013)
APOBEC3B is an enzymatic source of mutation in breast cancer
Michael B. Burns et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton et al.
NATURE BIOTECHNOLOGY (2013)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
Deciphering Signatures of Mutational Processes Operative in Human Cancer
Ludmil B. Alexandrov et al.
CELL REPORTS (2013)
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
V. Abkevich et al.
BRITISH JOURNAL OF CANCER (2012)
Mutational Processes Molding the Genomes of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
Kathryn Alsop et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Jonathan Ledermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Rohini Roy et al.
NATURE REVIEWS CANCER (2012)
Share Paper
